Objectives Oxidized low-density lipoprotein (oxLDL) plays a key role in the formation of atherosclerotic plaques. However, its localization in human coronary arterial wall is not well understood. The present study was performed to visualize deposition sites and patterns of native oxLDL and their relation to plaque morphology in human coronary artery. Methods Evans blue dye (EB) elicits a violet fluorescence by excitation at 345-nm and emission at 420-nm, and a reddish-brown fluorescence by excitation at 470-nm and emission at 515-nm characteristic of oxLDL only. Therefore, native oxLDL in excised human coronary artery were investigated by color fluorescent microscopy (CFM) using EB as a biomarker. Results (1) By luminal surface scan with CFM, the % incidence of oxLDL in 38 normal segments, 41 white plaques and 32 yellow plaques that were classified by conventional angioscopy, was respectively 26, 44 and 94, indicating significantly (p<0.05) higher incidence in the latter than the former two groups. Distribution pattern was classified as patchy, diffuse and web-like. Web-like pattern was observed only in yellow plaques with necrotic core. (2) By transected surface scan, oxLDL deposited within superficial layer in normal segments and diffusely within both superficial and deep layers in white and yellow plaques. In yellow plaques with necrotic core, oxLDL deposited not only in the marginal zone of the necrotic core but also in the fibrous cap. Conclusion Taken into consideration of the well-known process of coronary plaque growth, the results suggest that oxLDL begins to deposit in human coronary artery wall before plaque formation and increasingly deposits with plaque growth, exhibiting different deposition sites and patterns depending on morphological changes.
References
[1]
Fuster V, Badimon L (1992) The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med 326: 242–250.
[2]
Harvorsen B, Otterdal K, Dahl TB, Skjelland M, Gullestad L, et al. (2008) Atherosclerotic plaque stability -what determines the fate of plaque? Prog. Cardiovasc Dis. 51: 183–194.
[3]
Shah PK (2009) Inflammation and plaque vulnerability. Cardiovasc Drugs Ther 23: 31–40.
[4]
Chen JH, Riazzy M, Smith EM, Proud CG, Steinbrecher UP, et al. (2009) Oxidized LDL-mediated macrophage survival involves elongation factor-2 kinase. Arterioscler Thromb Vasc Biol 29: 92–98.
[5]
Park YM, Febbraio M, Silverstein RL (2009) CD36 modulates migration of mouse and human macrophages in response to oxidized LDL and may contribute to macrophage trapping in the arterial intima. Clin Invest 119: 136–145.
[6]
Matsuura E, Hughes GR, Khamashta MA (2008) Oxidation of LDL and its clinical implication. Autoimmun Rev. 7: 558–566.
[7]
Li W, Yuan XM, Olsson AG, Brunk UT (1998) Uptake of oxidized LDL by macrophages results in partial lysosomal enzyme inactivation and delocation. Arterioscler Thromb Vasc Biol. 18: 177–184.
[8]
Takahashi K, Takeya M, Sakashita N (2002) Multifunctional roles of macrophages in the development and progression of atherosclerosis in human and experimental animals. Med Electron Microsc 35: 179–203.
[9]
Shah PK, Falk E, Badimon JJ, Femandez-Ortiz A, Mailhac A, et al. (1995) Human monocyte-derived macrophages induce breakdown in fibrous caps of atherosclerotic plaques. Potential role of matrix-degrading metalloproteinases and implications for plaque rupture. Circulation 92: 1565–1569.
[10]
Ball RY, Stowers EC, Burton JH, Cary NR, Skepper JN, et al. (1995) Evidence that the death of macrophage foam cells contribute to the lipid core of atheroma. Atherosclerosis 114: 45–54.
[11]
Iuliano L, Signore A, Vallajosula S, Colavita AR, Camastra C, et al. (1996) Preparation and biodistribution of 99m technetium labeled oxidized LDL in man. Atherosclerosis. 126: 131–141.
[12]
Al Gadban MM, Smith KJ, Soodavar F, Piansay C, Chassereau C, et al. (2010) Differential trafficking of oxidized LDL and oxidized immune complexes in macrophages: impact on oxidative stress. PLoS ONE 5: 1–10.
[13]
Tsimikas S, Palinski W, Halpern SE, Yeung DW, Curtiss LK, et al. (1999) Radiolabeled MDA2, an oxidation-specific, monoclonal antibody, identifies native atherosclerotic lesions in vivo. J Nucl Cardiol 6: 41–53.
[14]
Briley-Saebo KC, Shaw PX, Mulder WJ, Choi SH, Vucic E, et al.. (2008) Targeted molecular probes for imaging atherosclerotic lesions with magnetic resonance using antibodies that recognize oxidation-specfic epitopes. Circulation 117; 3206–3215.
[15]
Fang L, Green SR, Baek JS, Lee SH, Ellett F, et al. (2011) In vivo visualiztion and attenuation of oxidized lipid accumulation in hypercholesteromic zebrafish. J Clin Invest 121: 4861–4869.
[16]
Vickers KC, Maquire CT, Wolfert R, Bums AR, Reardon M, et al. (2009) Relationship of lipoprotein-associated phospholipase A2 and oxidized low-density lipoprotein in carotid atherosclerosis. J Lipid Res. 50: 1735–1743.
[17]
Sigala F, Kotsinas A, Savari P, Filis K, Markantonis S, et al. (2010) Oxidized LDL in human carotid plaques is related to symptomatic carotid disease and lesion instability. J Vasc Surg. 52: 704–713.
[18]
Zaima N, Sasaki T, Tanaka H, Cheng XW, Onoue K, et al. (2011) Imaging mass spectroscopy-based histopathologic examination of atherosclerotic lesions. Atherosclerosis. 217: 427–432.
[19]
Kayo S, Ohsawa M, Ehara S, Naruko T, Ikura Y, et al. (2004) Oxidized low-density lipoprotein levels circulating in plasma and deposited in the tissues: comparison between Helicobacter pylori-associated gastritis and acute myocardial infarction. Am Heart J. 148: 818–825.
[20]
Fukuchi M, Watanabe J, Kumagai K, Baba S, Shinozaki T, et al. (2002) Normal and oxidized low-density lipoproteins accumulate deep in physiologically thickened intima of human coronary arteries. Lab Invest. 82: 1437–1447.
[21]
Uchida Y (2001) Angioscopy systems and their manipulation. In Coronary angioscopy. Uchida Y (ed) Futura Publishing LTD, Armonk, NY, 14–31.
[22]
Uchida Y, Nakamura F, Morita T (1995) Observation of atherosclerotic lesions by intravascular microscopy in patients with arteriosclerosis obliterans. Am Heart J 130: 1114–1119.
[23]
Terasawa K, Fujimori Y, Morio H, Ozegawa M, Uchida Y (2000) Evaluation of coronary endothelial damages caused by PTCA guide wires by in vivo dye staining angioscopy. J Jpn Coll Angiol 40: 159–164.
[24]
Uchida Y, Uchida H (2006) Therapeutic tool for vascular disease. United States Patent. US7025981 B2.
[25]
Uchida Y, Uchida Y, Kawai S, Kanamaru R, Sugiyama Y, et al. (2010) Detection of vulnerable coronary plaques by color fluorescent angioscopy. JACC Cardiovasc Imaging. 3: 398–408.
[26]
Uchida Y, Maezawa Y (2012) Molecular imaging of atherosclerotic coronary plaques by fluorescent angioscopy. In Molecular Imaging, Shaller B (ed), InTec Open Access Publisher, Rijeka, 247–257.
[27]
Yamada N (2002) Molecular biology of atherosclerosis. Nihonrinsyo. 60 (Suppl 10)87–98.
[28]
Uchida Y, Uchida Y, Hiruta N (2011) Histological characteristics of glistening yellow coronary plaques seen on angioscopy. Circ J. 75: 1913–1919.
[29]
Uchida Y (2001) Clinical classification of atherosclerotic coronary plaques. In: Uchida Y, editor. Coronary Angioscopy. Futura Publishing LTD, Armonk, NY, 71.
[30]
Okura Y, Brink M, Itabe H, Scheidegger KJ, Kalangos A, et al. (2000) Oxidized low-density lipoprotein is associated with apoptosis of vascular smooth muscle cells in human atherosclerotic plaques. Circulation 28: 2680–2686.
[31]
Uchida Y (2001) Histological basis for natural courses toward vulnerable plaques and disruption. In: Uchida Y, editor. Coronary angioscopy. Futura Publishing LTD, Armonk, NY. 51–55.
[32]
Itabe H, Suzuki K, Tsukamoto Y, Komatsu R, Ueda M, et al. (2000) Lysosomal accumulation of oxidized phospphatidylcholine-apolipoprotein B complex in macrophages: intracellular fate of oxidized low density lipoprotein. Biochim Biophys Acta. 1487: 233–245.
[33]
Yancey PG, Jerome WG (1998) Lysosomal sequestration of free and esterified cholesterol from oxidized low density lipoprotein in macrophages of different species. J Lipid Res. 39: 1349–1361.
[34]
Ovnichinnikova O, Gylfe A, Bailey L, Nordsrom A, Rudling M, et al.. (2009) Osteoprotegerin promotes fibrous cap formation in atherosclerotic lesions of Apo E-deficient mice- brief report. Arterioscler Thromb Vasc Biol. 1478–1480.
[35]
Uchida Y, Uchida Y, Kameda N (2010) Visualization of lipid components in human coronary plaques using color fluorescent angioscopy. Circ J. 74: 2181–2186.
[36]
Uchida Y, Maezawa Y, Uchida Y, Hiruta N, Shimoyama E (2012) Molecular imaging of low-density lipoprotein in human coronary plaques by color fluorescent angioscopy and microscopy. PLOS ONE 7: 1–9.
[37]
Uchida Y, Uchida Y, Sakurai T, Kanai M, Shirai S, et al. (2011) Characterization of coronary fibrin thrombus in patients with acute coronary syndrome using dye-staining angioscopy. Arterioscler Thromb Vasc Biol. 31: 1452–1460.
